VTE Linked to Higher Mortality Risk in Patients With CRC
LIVERTI Trial: Investigating Domvanalimab and Zimberelimab in Anti–PD-1–Resistant HCC
Federal Funding Cuts Will Likely Exacerbate GI Cancer Research Underfunding